
Feb 20 (Reuters) - Ionis Pharmaceuticals Inc IONS.O:
NEW POSITIVE DONIDALORSEN DATA TO BE PRESENTED AT AAAAI/WAO JOINT CONGRESS HIGHLIGHT SUSTAINED HAE ATTACK RATE REDUCTION AND DISEASE CONTROL
Source text: ID:nBw7Nkf93a
Further company coverage: IONS.O